GLUCOTRACK PROVIDES SHAREHOLDER UPDATE
14 mars 2023 10h00 HE
|
GlucoTrack, Inc.
Rutherford, NJ, March 14, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h45 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h30 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEM
10 oct. 2022 08h30 HE
|
GlucoTrack, Inc.
Rutherford, NJ, Oct. 10, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a non-invasive device and digital health platform for measuring glucose levels in...
GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor
22 juin 2022 08h30 HE
|
GlucoTrack, Inc.
Rutherford, NJ and Or Yehuda, Israel, June 22, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a non-invasive device and digital health platform for...